Schroder Investment Management Group
BNTX icon

Schroder Investment Management Group’s BioNTech BNTX Stock Holding History

Schroder Investment Management Group’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-278,584
Closed -$62.4M – 1488
2021
Q2 		$62.4M Buy
278,584
+216,371
+348% +$40.8M 0.08% 256
2021
Q1 		$6.79M Buy
62,213
+4,606
+8% +$489K 0.01% 752
2020
Q4 		$4.7M Buy
57,607
+17,262
+43% +$1.69M 0.01% 815
2020
Q3 		$2.97M Sell
40,345
-6,068
-13% -$435K ﹤0.01% 827
2020
Q2 		$3.1M Sell
46,413
-10,261
-18% -$512K 0.01% 750
2020
Q1 		$2.99M Sell
56,674
-36,122
-39% -$1.41M 0.01% 749
2019
Q4 		$3.14M Buy
+92,796
New +$2.08M 0.01% 814

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Schroder Investment Management Group's BNTX Position: Q3 2021 in Review

Schroder Investment Management Group sold out of BioNTech (BNTX) in Q3 2021, closing a stake of 278,584 shares — an estimated $62.4M sold.

Schroder Investment Management Group first reported a position in BNTX in Q4 2019 and held it in 7 quarters. The position peaked at $62.4M in Q2 2021. 335 funds tracked by Wall St. Rank hold BNTX as of Q3 2021.

  • Schroder Investment Management Group reported no remaining BioNTech position as of Q3 2021 after selling out during the quarter.
  • Schroder Investment Management Group sold 278,584 BioNTech shares in Q3 2021, an estimated $62.4M.
  • Schroder Investment Management Group first reported a position in BioNTech in Q4 2019 and held it in 7 quarters.
  • Schroder Investment Management Group's BioNTech position peaked at $62.4M in Q2 2021.
  • 335 funds tracked by Wall St. Rank held BioNTech as of Q3 2021.

Based on Schroder Investment Management Group's 13F filing for Q3 2021, filed 12 Nov 2021.